Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
CORTROPHIN-ZINC is a corticotropin (ACTH) analog formulated as a zinc hydroxide complex for intramuscular or subcutaneous injection. It stimulates the adrenal cortex to produce endogenous corticosteroids, used historically for anti-inflammatory and immunosuppressive conditions. The drug represents a legacy biologic from the 1950s era of hormone-based therapeutics.
Declining market relevance with minimal contemporary commercialization activity; career growth limited by product maturity and lack of active promotion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on CORTROPHIN-ZINC offers limited career advancement opportunity; roles focus on maintaining regulatory status and operational continuity rather than growth strategy or market expansion. This product is suitable only for professionals seeking stability in a legacy portfolio, not career acceleration.
Worked on CORTROPHIN-ZINC at ANI Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.